Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ito

Showing results (271-280 of 288) with videos related to

Pageof 29
Sort By:
Bone Marrow Transplantation|January 12, 2016
Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantationY Tanaka, S Kurosawa, K Tajima, et al.
Arthritis and Rheumatism|May 15, 2003
Genetic basis of tissue specificity of vasculitis in MRL/lpr miceAkihiro Yamada, Tatsuhiko Miyazaki, Ling-Min Lu, et al.
Bone Marrow Transplantation|March 21, 2017
Clinical impact of hyperglycemia on days 0-7 after allogeneic stem cell transplantationA Kawajiri, S Fuji, Y Tanaka, et al.
Ophthalmic Genetics|July 27, 1999
Visual impairment and REP-1 gene mutations in Japanese choroideremia patientsM Hayakawa, K Fujiki, Y Hotta, et al.
Kidney International|April 17, 2004
Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus modelsKimihiko Nakatani, Hiroshi Fujii, Hitoshi Hasegawa, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 21, 2016
Discordant signaling and autophagy response to fasting in hearts of obese mice: Implications for ischemia toleranceAllen M Andres, Joel A Kooren, Sarah J Parker, et al.
Kidney International|October 9, 2003
Internalization of antibodies by endothelial cells via fibronectin implicating a novel mechanism in lupus nephritisHiroshi Fujii, Kimihiko Nakatani, Norimasa Arita, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2007
Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic indexMark D Erion, Edward E Cable, Bruce R Ito, et al.
British Journal of Pharmacology|February 3, 2009
Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeysB R Ito, B-H Zhang, E E Cable, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 16, 2008
Preclinical pharmacokinetics of a HepDirect prodrug of a novel phosphonate-containing thyroid hormone receptor agonistJames M Fujitaki, Edward E Cable, Bruce R Ito, et al.
Pageof 29

Showing results (271-280 of 288) with videos related to

Sort By:
Pageof 29
Bone Marrow Transplantation|January 12, 2016
Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantationY Tanaka, S Kurosawa, K Tajima, et al.
Arthritis and Rheumatism|May 15, 2003
Genetic basis of tissue specificity of vasculitis in MRL/lpr miceAkihiro Yamada, Tatsuhiko Miyazaki, Ling-Min Lu, et al.
Bone Marrow Transplantation|March 21, 2017
Clinical impact of hyperglycemia on days 0-7 after allogeneic stem cell transplantationA Kawajiri, S Fuji, Y Tanaka, et al.
Ophthalmic Genetics|July 27, 1999
Visual impairment and REP-1 gene mutations in Japanese choroideremia patientsM Hayakawa, K Fujiki, Y Hotta, et al.
Kidney International|April 17, 2004
Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus modelsKimihiko Nakatani, Hiroshi Fujii, Hitoshi Hasegawa, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 21, 2016
Discordant signaling and autophagy response to fasting in hearts of obese mice: Implications for ischemia toleranceAllen M Andres, Joel A Kooren, Sarah J Parker, et al.
Kidney International|October 9, 2003
Internalization of antibodies by endothelial cells via fibronectin implicating a novel mechanism in lupus nephritisHiroshi Fujii, Kimihiko Nakatani, Norimasa Arita, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2007
Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic indexMark D Erion, Edward E Cable, Bruce R Ito, et al.
British Journal of Pharmacology|February 3, 2009
Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeysB R Ito, B-H Zhang, E E Cable, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 16, 2008
Preclinical pharmacokinetics of a HepDirect prodrug of a novel phosphonate-containing thyroid hormone receptor agonistJames M Fujitaki, Edward E Cable, Bruce R Ito, et al.
Pageof 29